- Home
- DRIO vs BNGO Comparison
DRIO vs BNGO Comparison
Compare DRIO & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRIO
- BNGO
- Stock Information
- Founded
- DRIO 2011
- BNGO 2003
- Country
- DRIO United States
- BNGO United States
- Employees
- DRIO N/A
- BNGO N/A
- Industry
- DRIO Medical/Dental Instruments
- BNGO Biotechnology: Laboratory Analytical Instruments
- Sector
- DRIO Health Care
- BNGO Industrials
- Exchange
- DRIO Nasdaq
- BNGO Nasdaq
- Market Cap
- DRIO 21.9M
- BNGO 24.3M
- IPO Year
- DRIO N/A
- BNGO 2018
- Fundamental
- Price
- DRIO $7.11
- BNGO $3.88
- Analyst Decision
- DRIO Strong Buy
- BNGO Buy
- Analyst Count
- DRIO 2
- BNGO 4
- Target Price
- DRIO $50.00
- BNGO $7.67
- AVG Volume (30 Days)
- DRIO 31.2K
- BNGO 260.0K
- Earning Date
- DRIO 11-06-2025
- BNGO 11-12-2025
- Dividend Yield
- DRIO N/A
- BNGO N/A
- EPS Growth
- DRIO N/A
- BNGO N/A
- EPS
- DRIO N/A
- BNGO N/A
- Revenue
- DRIO $27,148,000.00
- BNGO $27,426,000.00
- Revenue This Year
- DRIO $0.74
- BNGO N/A
- Revenue Next Year
- DRIO $19.61
- BNGO $20.81
- P/E Ratio
- DRIO N/A
- BNGO N/A
- Revenue Growth
- DRIO 41.79
- BNGO N/A
- 52 Week Low
- DRIO $7.02
- BNGO $2.68
- 52 Week High
- DRIO $31.00
- BNGO $30.52
- Technical
- Relative Strength Index (RSI)
- DRIO 31.31
- BNGO 51.09
- Support Level
- DRIO $8.91
- BNGO $3.55
- Resistance Level
- DRIO $10.60
- BNGO $5.50
- Average True Range (ATR)
- DRIO 0.98
- BNGO 0.45
- MACD
- DRIO -0.19
- BNGO 0.01
- Stochastic Oscillator
- DRIO 1.61
- BNGO 16.92
About DRIO DarioHealth Corp.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
About BNGO Bionano Genomics Inc.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.